Related Experiment Video

Updated: May 19, 2026

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry

Published on: November 23, 2011

The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues

Nina Krompholz1, Carmen Krischkowski, Debora Reichmann

  • 1Pharmaceutical Institute, Christian-Albrechts-University of Kiel, Germany 24118.

Chemical Research in Toxicology
|August 29, 2012
PubMed

Insights

The mammalian mitochondrial Amidoxime Reducing Component (mARC) enzyme system detoxifies harmful N-hydroxylated nucleobases. This discovery suggests mARC proteins protect cellular DNA from mutagenic base analogue misincorporation.

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • Mitochondrial Amidoxime Reducing Component (mARC) is the fourth molybdenum enzyme identified in mammals.
  • Mammals express two mARC proteins, mARC1 and mARC2, which form a three-component system with cytochrome b(5) and NADH cytochrome b(5) reductase.
  • This system catalyzes the reduction of N-hydroxylated prodrugs.

Purpose of the Study:

  • To investigate the reductive detoxification of toxic N-hydroxylated nucleobases and nucleosides by the mammalian mARC enzyme system.
  • To determine the tissue distribution and subcellular localization of this N-reductive activity.
  • To assess the substrate specificity and efficiency of mARC1 and mARC2 in reducing N-hydroxylated base analogues.

Main Methods:

  • In vitro assays using recombinant mARC enzyme systems.
  • Analysis of N-reductive activity across various mammalian tissues.
  • Fractionation of cellular components to isolate mitochondrial activity.

Main Results:

  • The mARC enzyme system effectively reduces toxic and mutagenic N-hydroxylated nucleobases and nucleosides.
  • Highest N-reductive activity was observed in liver, kidney, thyroid, and pancreas, primarily in mitochondrial fractions.
  • Both mARC1 and mARC2 reduced N-hydroxylated base analogues, with mARC1 being more efficient.

Conclusions:

  • Mammalian mARC proteins play a crucial role in the reductive detoxification of N-hydroxylated compounds.
  • The mARC system likely protects cellular DNA from damage by converting toxic N-hydroxylated base analogues into correct purine or pyrimidine bases.
  • This finding highlights a novel protective mechanism against DNA damage during replication.

More Related Videos

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools05:27

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools

Published on: July 20, 2022

High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution10:47

High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution

Published on: May 5, 2023

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...